Washington, D.C. 20549






Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

under the Securities Exchange Act of 1934

For the month of May, 2022

Commission File Number 001-39670




(Translation of registrant’s name into English)



6 Tide Street, Suite 400

Boston, Massachusetts 02210

(Address of principal executive office)



Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐





On May 9, 2022, PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (the “Company”) announced the commencement of a $50 million share repurchase program (the “Program”) of its ordinary shares of one pence each (“Ordinary Shares”). The Company plans to execute the Program in two equal tranches. In respect of the first tranche, PureTech entered into an irrevocable non-discretionary instruction with Jefferies International Limited (“Jefferies”) in relation to the purchase by Jefferies of Ordinary Shares for an aggregate consideration (excluding expenses) of no greater than $25 million and the simultaneous on-sale of such Ordinary Shares by Jefferies to PureTech. Jefferies makes its trading decisions in relation to the Ordinary Shares independently of, and uninfluenced by, the Company. Purchases may continue during any close period to which the Company is subject. Any purchase of Ordinary Shares under the first tranche of the Program are carried out on the London Stock Exchange and any other UK recognized investment exchange which may be agreed, in accordance with pre-set parameters and in accordance with, and subject to limits, including those limits related to daily volume and price, prescribed by the Company’s general authority to repurchase Ordinary Shares granted by its shareholders at its most recent annual general meeting on May 27, 2021, Chapter 12 of the Financial Conduct Authority’s UK Listing Rules, Article 5(1) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) and Commission Delegated Regulation (EU) 2016/1052 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018). All Ordinary Shares repurchased under the Program will be held in treasury.

During the month ended May 31, 2022, the Company had the following daily purchases of its own Ordinary Shares under the Program through Jefferies:



   Ordinary Shares
     Volume Weighted
Average Price Paid
per Ordinary Share
     Highest Price Paid      Lowest Price Paid  

May 9, 2022

     29,545        163.88p        170.20p        161.00p  

May 10, 2022

     43,836        162.46p        166.40p        157.40p  

May 11, 2022

     44,630        172.17p        175.80p        167.00p  

May 12, 2022

     46,379        169.35p        173.20p        166.20p  

May 13, 2022

     21,361        174.64p        174.80p        172.80p  

May 16, 2022

     47,323        175.29p        176.40p        173.40p  

May 17, 2022

     46,037        177.35p        179.20p        174.20p  

May 18, 2022

     47,109        179.57p        181.00p        177.20p  

May 19, 2022

     46,603        175.29p        180.00p        171.00p  

May 20, 2022

     50,363        183.11p        185.20p        179.40p  

May 23, 2022

     50,950        184.49p        185.80p        181.40p  

May 24, 2022

     50,056        176.67p        183.00p        172.20p  

May 25, 2022

     49,379        175.03p        177.00p        170.00p  

May 26, 2022

     47,160        178.84p        180.20p        173.80p  

May 27, 2022

     47,919        180.78p        185.00p        177.80p  

May 30, 2022

     25,217        185.17p        186.00p        183.80p  

May 31, 2022

     49,249        184.70p        186.60p        179.00p  

During the month ended May 31, 2022, the Company repurchased an aggregate of 743,116 Ordinary Shares. As of May 31, 2022, the Company’s issued share capital was 288,611,120 shares, 743,116 of which were held in treasury, resulting in total voting rights in the Company of 287,868,004 shares. To view the details of the individual transactions, please paste the following URL(s) into the address bar of your browser with respect to each individual date of repurchase under the Program:

May 9, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4363881.html

May 10, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4365501.html

May 11, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4367138.html

May 12, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4368852.html

May 13, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4370531.html

May 16, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4372195.html

May 17, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4373834.html

May 18, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4375570.html

May 19, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4377110.html

May 20, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4378718.html

May 23, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4380434.html

May 24, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4382153.html

May 25, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4383727.html

May 26, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4385273.html

May 27, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4386847.html

May 30, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4388273.html

May 31, 2022: https://data.fca.org.uk/artefacts/NSM/RNS/4390083.html


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


Date: June 3, 2022   By:  

/s/ Daphne Zohar

    Name:   Daphne Zohar
    Title:   Chief Executive Officer